Soft tumor environments can cause triple-negative breast cancer to spread more aggressively. Darwin Kwok discusses how he felt about winning the award and what he’s learned from past recipients. The use of a 3D variable flip angle mapping technique is effective in patients with head and neck cancer undergoing CRT. A blood-based machine learning assay may be able to differentiate patients with ovarian cancer from healthy patients. Patients with a history of venous thromboembolism were more likely to receive VTE prophylaxis. Patients ≥70 years of age were more likely to have a reduction in their palbociclib dosage. Rates of treatment-related hypersensitivity reactions were low in an academic community setting. Same-day administration of pegfilgrastim was not linked to a greater incidence of grade ≥3 neutropenia. Lenvatinib plus pembrolizumab led to a clinically relevant response in patients with baseline metastasis. Higher average talazoparib concentrations were associated with an increased risk of severe anemia and thrombocytopenia. Decreasing the at-home dose of dexamethasone before paclitaxel treatment may help reduce the incidence of infusion reactions. Protected administrative time was ranked as the most important change to improve well-being. Ibrutinib dose reductions were associated with fewer recurrent cardiac adverse events in patients with B-cell malignancies. The REMEDY trial evaluated remote continuous temperature monitoring in patients receiving cytotoxic chemotherapy. Cemiplimab plus chemotherapy as a first-line treatment for advanced NSCLC led to improved survival. Dr. Samilia Obeng-Gyasi discusses how social factors can impact outcomes in breast cancer patients. Ovarian cancer patients value personalized follow-up care and reassurance. For women with BRCA1 sequence variations, MRI surveillance is linked to lower breast cancer mortality. A study found a "substantial deficit" of undiagnosed cancer cases during the COVID-19 pandemic. Many cardio-oncology patients at increased risk for congestive heart failure from cancer therapy have OSA.